Smoking Is Related to Worse Cancer-related Symptom Burden. (11th February 2022)

• Record Type: Journal Article
• Authors: Oswald, Laura B; Brownstein, Naomi C; Whiting, Junmin; Hoogland, Aasha I; Saravia, Sabrina; Kirtane, Kedar; Chung, Christine H; Vinci, Christine; Gonzalez, Brian D; Johnstone, Peter A S; Jim, Heather S L
• Is Part Of: Oncologist. Volume 27:Number 2(2022)
• Page Start: e176
• Page End: e184
• Publication Date: 2022-02-11
• Subjects: cancer -- cigarette smoking -- patient-reported outcomes -- symptom burden; Oncology -- Periodicals; Tumors -- Periodicals; Cancérologie -- Périodiques; Tumeurs -- Périodiques; Oncology; Tumors; Neoplasms; Electronic journals; Periodicals; Periodicals; 616.994
• DOI: 10.1093/oncolo/oyab029
• Languages: English
• ISSNs: 1083-7159

Abstract

Abstract: Background: Cigarette smoking is related to greater cancer incidence, worse cancer-related clinical outcomes, and worse patient quality of life. Few studies have evaluated the role of smoking in patients' experiences of cancer-related symptom burden. This study examined relationships between smoking and total symptom burden as well as the incidence of severe symptoms among adult cancer patients. Patients and Methods: Patients at Moffitt Cancer Center completed self-report surveys as part of routine cancer care. Symptom burden was evaluated as the sum of individual symptom ratings (total symptom burden) and the number of symptoms rated severe (incidence of severe symptoms). Zero-inflated negative binomial modeling was used to evaluate the relationships between smoking status (ever vs never smoker) and symptom burden outcomes controlling for relevant sociodemographic and clinical covariates and accounting for the proportion of participants reporting no symptom burden. Results: This study included 12 571 cancer patients. More than half reported a history of cigarette smoking ( n = 6771, 55%). Relative to never smokers, participants with a smoking history had 15% worse expected total symptom burden (ratio = 1.15, 95% confidence interval [CI] 1.11-1.20, P < .001) and 13% more expected severe symptoms (ratio = 1.13, 95% CI 1.05-1.21, P = .001) above and beyond the effects of relevant sociodemographic and clinical characteristics. Conclusion: Results provide support that smoking is associated with worse cancer symptom burden. More research is needed to evaluate how smoking history (ie, current vs former smoker) and smoking cessation influence cancer symptom burden. Abstract : Few studies have evaluated the role of smoking in patients' experiences of cancer-related symptom burden. This article examines relationships between smoking and total symptom burden, as well as incidence of severe symptoms among adult cancer patients.